Inhibition of UCP2 in UCP2-overexpressing breast cancer cells (MCF7 UCP2) by genipin resulted in a reduction in UCP2 tumorigenic properties, reduced cell proliferation, clonogenic survival and matrigel invasion [80]. This evidence concerns the gene UCP2 and breast carcinoma.